| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Mouse Embryo Cells to Focus Formation and Anchorage Independence by Insoluble Lead Chromate but not Soluble Calcium Chromate: Relationship to Mutagenesis and Internalization of Lead Chromate Particles1
Department of Microbiology and USC Comprehensive Cancer Center, Norris Cancer Hospital and Research Institute, University of Southern California School of Medicine, Los Angeies, California 90033.
The genotoxicity of soluble and insoluble hexavalent chromium compounds was studied in mammalian cell assays which detect base substitution, deletion, addition, and frameshift mutations [6-thioguanine resistance in Chinese hamster ovary cells], primarily base substitution mutations [ouabain resistance in Chinese hamster ovary and C3H/10T
Cl 8 mouse embryo fibroblasts (10T
)] and morphological transformation [focus formation] in 10T
cells. Soluble hexavalent CaCrO4, administered in either acute (5-h) or subacute (24-h) dosing regimens, induced dose-dependent cytotoxicity and mutation to 6-thioguanine resistance in Chinese hamster ovary cells but no mutation to ouabain resistance or focus formation in transformation assays, although the acute treatment induced a high frequency of conversion of 10T
cells to adipocytes. Cell lines established from cloned adipocytic cells were not morphologically transformed and did not grow in soft agarose. PbCrO4 did not induce mutation to either 6-thioguanine or ouabain resistance but did induce a reproducible dose-dependent, low frequency of focus formation in 10T
cells. Cell lines established from PbCrO4-induced foci stably formed foci when coseeded with 10T
cells, had 35-fold increased saturation densities relative to nontransformed 10T
cells, and formed colonies in soft agarose, indicating their likelihood to be neoplastic. Long term exposure of 10T
cells to either CaCrO4 or PbCl2, even at 85% cytotoxic concentrations, or pretreatment of cells with either CaCrO4 or PbCl2 followed by treatment with the alternate compound, did not induce morphological transformation. Treatment of cells with insoluble hexavalent PbCrO4 resulted in progressive and extensive vacuolization of cells in contact with the particles. Progressive cytoplasmic engulfment of PbCrO4 particles was observed using scanning electron microscopy, although PbCrO4 particles were not observed inside vacuoles.
These results indicated that the soluble clastogens K2Cr2O7 and CaCrO4 were probably mutagenic by a non-base substitution mechanism but could not transform 10T
cells. In contrast, PbCrO4 was not detectably mutagenic but induced transformation, which could not be explained solely by acute or chronic exposure to dissolution products of either lead or chromate alone. Since PbCrO4 particles were found to be intracytoplasmic in extensively vacuolated cells, we suggest that the unique physicochemical properties of PbCrO4 particles, leading to their internalization and the resultant associated cellular stress response, may be related to the transformation induced by this compound.
1 This work was supported by Grant ES03341 from the National Institute of Environmental Health Sciences, NIH, and by a grant from the R. J. Reynolds Company to Joseph R. Landolph.
2 Supported by National Cancer Institute (NIH) Training Grant T32 CA 09320 in Chemical and Viral Carcinogenesis and a National Institute of Environmental Health Sciences Individual Postdoctoral Fellowship Award. Present address: Department of Pharmacology, George Washington University Medical School, 2300 Eye St. N.W., Washington, DC 20337.
3 To whom requests for reprints should be addressed, at USC Comprehensive Cancer Center, K. Norris Jr. Cancer Hospital, Department of Microbiology, Box 33800, 2025 Zonal Ave., Los Angeles, CA 90033-0800.
Received 1/15/88. Revised 5/11/88. Accepted 6/21/88.
This article has been cited by other articles:
![]() |
P. Joseph, Q. He, and C. Umbright Heme-oxygenase 1 Gene Expression is a Marker for Hexavalent Chromium-Induced Stress and Toxicity in Human Dermal Fibroblasts Toxicol. Sci., June 1, 2008; 103(2): 325 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xie, A. L. Holmes, S. S. Wise, S. Huang, C. Peng, and J. P. Wise Sr. Neoplastic Transformation of Human Bronchial Cells by Lead Chromate Particles Am. J. Respir. Cell Mol. Biol., November 1, 2007; 37(5): 544 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Camyre, S. S. Wise, P. Milligan, N. Gordon, B. Goodale, M. Stackpole, N. Patzlaff, A.-M. Aboueissa, and J. P. Wise Sr Ku80 Deficiency Does Not Affect Particulate Chromate-Induced Chromosome Damage and Cytotoxicity in Chinese Hamster Ovary Cells Toxicol. Sci., June 1, 2007; 97(2): 348 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Grlickova-Duzevik, S. S. Wise, R. C. Munroe, W. D. Thompson, and J. P. Wise Sr XRCC1 Protects against Particulate Chromate-Induced Chromosome Damage and Cytotoxicity in Chinese Hamster Ovary Cells Toxicol. Sci., August 1, 2006; 92(2): 409 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Grlickova-Duzevik, S. S. Wise, R. C. Munroe, W. D. Thompson, and J. P. Wise Sr XRCC1 Protects against Particulate Chromate-Induced Chromosome Damage and Cytotoxicity in Chinese Hamster Ovary Cells Toxicol. Sci., July 1, 2006; 92(1): 96 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Clemens and J. R. Landolph Genotoxicity of Samples of Nickel Refinery Dust Toxicol. Sci., May 1, 2003; 73(1): 114 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Pritchard, S. Ceryak, L. Ha, J. L. Fornsaglio, S. K. Hartman, T. J. O'Brien, and S. R. Patierno Mechanism of Apoptosis and Determination of Cellular Fate in Chromium(VI)-exposed Populations of Telomerase-immortalized Human Fibroblasts Cell Growth Differ., October 1, 2001; 12(10): 487 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Miller, S. Mog, L. McKinney, L. Luo, J. Allen, J. Xu, and N. Page Neoplastic transformation of human osteoblast cells to the tumorigenic phenotype by heavy metal-tungsten alloy particles: induction of genotoxic effects Carcinogenesis, January 1, 2001; 22(1): 115 - 125. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |